Wells Fargo & Company Neuronetics, Inc. Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Neuronetics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 10,215 shares of STIM stock, worth $17,876. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,215

Previous 10,211 0.04%

Holding current value

$17,876

Previous $29,000 65.52%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$2.68 - $4.8 $10 - $19	4 Added 0.04%	10,215 $48,000
Q4 2023 Feb 09, 2024	BUY	$1.05 - $2.9 $10,511 - $29,031	10,011 Added 5005.5%	10,211 $29,000
Q3 2023 Nov 13, 2023	SELL	$1.29 - $2.22 $6 - $11	-5 Reduced 2.44%	200 $0
Q2 2023 Aug 15, 2023	BUY	$2.07 - $2.92 $35 - $49	17 Added 9.04%	205 $0
Q1 2023 May 12, 2023	BUY	$2.81 - $6.71 $8 - $20	3 Added 1.62%	188 $0

Q4 2022 Feb 13, 2023	BUY	$3.44 - $6.87 $20 - $41	6 Added 3.35%	185 $1,000
Q2 2022 Aug 12, 2022	SELL	$2.09 - $3.71 $30,975 - $54,985	-14,821 Reduced 98.81%	179 $1,000
Q1 2022 May 16, 2022	SELL	$2.84 - $4.52 $25,273 - $40,223	-8,899 Reduced 37.24%	15,000 $45,000
Q4 2021 Feb 14, 2022	SELL	$3.87 - $6.59 $733,121 - $1.25 Million	-189,437 Reduced 88.8%	23,899 $106,000
Q3 2021 Nov 15, 2021	SELL	$6.22 - $15.54 $1.95 Million - $4.87 Million	-313,364 Reduced 59.5%	213,336 $1.4 Million
Q2 2021 Aug 16, 2021	BUY	$10.15 - $17.25 $149,986 - $254,903	14,777 Added 2.89%	526,700 $8.44 Million
Q1 2021 May 13, 2021	BUY	$10.6 - $21.27 $5.33 Million - $10.7 Million	502,628 Added 5407.51%	511,923 $6.33 Million
Q4 2020 Feb 09, 2021	BUY	$4.95 - $11.45 $5,969 - $13,808	1,206 Added 14.91%	9,295 $103,000
Q3 2020 Nov 05, 2020	BUY	$1.82 - $5.87 $11,702 - $37,744	6,430 Added 387.58%	8,089 $39,000
Q2 2020 Aug 13, 2020	SELL	$1.41 - $2.61 $50,111 - $92,759	-35,540 Reduced 95.54%	1,659 $3,000
Q1 2020 May 14, 2020	BUY	$1.28 - $4.5 $47,614 - $167,395	37,199 New	37,199 $70,000

Others Institutions Holding STIM

# of Institutions

Shares Held

18.4M

Call Options Held

200

Put Options Held

3.6K

View Full List

About Neuronetics, Inc.

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $47.3M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

More about STIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Neuronetics, Inc. Transaction History